IONS profile · all as-reported value updates

IONIS PHARMACEUTICALS INC (IONS) as-reported value updates

Descriptive filing record — not investment advice. This page compares two SEC XBRL-filed values for the same fiscal period. It does not state why the values differ and is not a rating, score, or recommendation. See Disclaimer.

Reported values for the same fiscal period can differ between filings for many routine reasons: re-presentation for discontinued operations, adoption of new accounting standards, reclassifications, changes in rounding precision, and amendments. This ledger records that the filed values differ; it does not and cannot determine why. Both filings are linked below so the reader can consult the source.

Rows publish only when the later filed value differs by at least 1.0% and at least $1,000,000, after dropping differences that match under the capped trailing-zero precision rule. The delta percent is delta divided by the larger absolute filed value. Values are annual standardized facts only; metrics whose differences fall below those thresholds or match the capped precision rule are not published as rows.

Ledger table figure

Metric	FY	Earliest XBRL-filed value	Currently on file	Difference	Difference %	Label	Filing links	Notes
Net income NetIncomeLoss	2017	-5,970,000 filed 2018-02-28 · 10-K	346,000 filed 2020-03-02 · 10-K	6,316,000	+105.80%	revised comparative figure	0000874015-18-000047 0001140361-20-004500	3 filed observations examined for this concept and period.
Operating income OperatingIncomeLoss	2016	-46,316,000 filed 2017-03-01 · 10-K	-20,160,000 filed 2019-03-01 · 10-K	26,156,000	+56.47%	revised comparative figure	0001140361-17-009823 0000874015-19-000045	3 filed observations examined for this concept and period.
Net income NetIncomeLoss	2016	-86,556,000 filed 2017-03-01 · 10-K	-60,400,000 filed 2019-03-01 · 10-K	26,156,000	+30.22%	revised comparative figure	0001140361-17-009823 0000874015-19-000045	3 filed observations examined for this concept and period.
Operating income OperatingIncomeLoss	2017	24,534,000 filed 2018-02-28 · 10-K	31,047,000 filed 2020-03-02 · 10-K	6,513,000	+20.98%	revised comparative figure	0000874015-18-000047 0001140361-20-004500	3 filed observations examined for this concept and period.
Stockholders' equity StockholdersEquity	2017	330,872,000 filed 2018-02-28 · 10-K	281,013,000 filed 2019-03-01 · 10-K	-49,859,000	-15.07%	revised comparative figure	0000874015-18-000047 0000874015-19-000045	2 filed observations examined for this concept and period.
Stockholders' equity StockholdersEquity	2020	843,347,000 filed 2021-02-24 · 10-K	743,282,000 filed 2024-02-21 · 10-K	-100,065,000	-11.87%	revised comparative figure	0000874015-21-000056 0000874015-24-000116	3 filed observations examined for this concept and period.
Liabilities Liabilities	2020	1,546,408,000 filed 2021-02-24 · 10-K	1,646,473,000 filed 2022-02-25 · 10-K	100,065,000	+6.08%	revised comparative figure	0000874015-21-000056 0000874015-22-000079	2 filed observations examined for this concept and period.
Liabilities Liabilities	2017	903,305,000 filed 2018-02-28 · 10-K	957,494,000 filed 2019-03-01 · 10-K	54,189,000	+5.66%	revised comparative figure	0000874015-18-000047 0000874015-19-000045	2 filed observations examined for this concept and period.
Net income NetIncomeLoss	2019	294,146,000 filed 2020-03-02 · 10-K	278,143,000 filed 2022-02-25 · 10-K	-16,003,000	-5.44%	revised comparative figure	0001140361-20-004500 0000874015-22-000079	3 filed observations examined for this concept and period.
Net income NetIncomeLoss	2020	-451,286,000 filed 2021-02-24 · 10-K	-444,263,000 filed 2023-02-22 · 10-K	7,023,000	+1.56%	revised comparative figure	0000874015-21-000056 0000874015-23-000105	3 filed observations examined for this concept and period.